Exclusive Summary

• • A Potential Best-in-class AR degrader.
• • Capable of degrading AR gene amplification and drug-resistant mutations in the AR-LBD domain, including the L702H mutation.
• • In vitro and in vivo activity is significantly superior to that of ARV766.